INSIGHTS

Articles & Insights.

Thought leadership on the legal, regulatory, and business issues shaping the healthcare industry.

REAL ISSUES.

PRACTICAL INSIGHTS.

AHEAD OF THE CURVE.

Two OIG Advisory Opinions Explain When Healthcare Referral Platforms Create Anti-Kickback Risk

Healthcare Referral Platforms Create Anti-Kickback Risk

Healthcare companies increasingly rely on technology to connect patients with medical practices, laboratories, pharmacies, home health agencies, and other providers.

Referral platforms can improve coordination and patient access.

But the compensation structure supporting the platform can create significant regulatory exposure.

Two advisory opinions issued by the HHS Office of Inspector General in 2026 illustrate the distinction between potentially permissible referral services and arrangements that create inappropriate financial incentives.

A Favorable Opinion for a Referral Service

On September 9, 2026, OIG published Advisory Opinion 26-18.

The opinion evaluated a proposed referral service connecting patients requiring specialized ear and hearing healthcare services with participating professionals.

Under the arrangement, participating professional groups would pay fees to support the referral service.

OIG concluded that the proposed structure satisfied the federal Anti-Kickback Statute’s referral-services safe harbor.

Important facts included uniform fees, compensation based on operating costs rather than referral volume, patient disclosures, and preservation of professional autonomy. 

An Unfavorable Opinion Involving Referral Software

Earlier in 2026, OIG issued Advisory Opinion 26-15 involving an online referral-management platform used by home health agencies.

The platform allowed subscribing providers to receive and respond electronically to hospital referral opportunities.

Non-subscribing providers relied on slower communication methods.

OIG expressed concern that paying for the platform created a meaningful advantage in obtaining patient referrals.

The agency concluded that the arrangement did not satisfy the referral-services safe harbor and presented more than minimal fraud-and-abuse risk.

The opinion was unfavorable to the requesting party. 

The Difference Is Not Simply Fixed Fees Versus Percentage Fees

Healthcare entrepreneurs sometimes assume that a fixed monthly fee automatically resolves referral concerns.

That is not necessarily correct.

A fixed subscription payment can still create regulatory exposure if the payment effectively purchases preferential access to federally reimbursable patients.

The central questions concern what the company is selling, how providers are selected, how patients are directed, and whether compensation influences referral opportunities.

Technology Does Not Eliminate Referral Laws

An arrangement does not become permissible merely because the referral occurs through software.

The same issues can arise through online patient marketplaces, scheduling platforms, lead-generation systems, marketing companies, and technology intermediaries.

Businesses should evaluate the full relationship rather than relying exclusively on the agreement’s description of the services.

State Law Creates Additional Considerations

The federal Anti-Kickback Statute is only part of the analysis.

State patient-brokering, fee-splitting, professional practice, and other regulations may impose separate restrictions.

For example, Florida healthcare businesses should evaluate the state’s Patient Brokering Act when developing compensated referral or marketing relationships.

OIG advisory opinions are also fact-specific and legally binding only with respect to the requesting parties.

They provide guidance, not universal immunity.

Apex Health Law advises healthcare companies, MSOs, medical practices, laboratories, pharmacies, and marketing organizations regarding referral relationships, compensation arrangements, and fraud-and-abuse compliance.

This article is provided for general informational purposes only and does not constitute legal advice.

Regulatory reference: HHS-OIG Advisory Opinions⁠

Share:

More Posts

Send A Message